22.626 articles found

[Parkinson treatment--where to begin?].

Oberpichler-Schwenk H.

Med Monatsschr Pharm · 2009-04-01

PMID: 19445267

Effects of pituitary adenylate cyclase activating polypeptide and its fragments on retinal degeneration induced by neonatal monosodium glutamate treatment.

Atlasz T, Szabadfi K, Reglodi D, Kiss P, Tamás A, Tóth G, Molnár A, Szabó K, Gábriel R.

Ann N Y Acad Sci · 2009-04-01

DOI: 10.1111/j.1749-6632.2008.03650.xPMID: 19456357

[Treatment of early Parkinson's disease].

Delvaux V, Moonen G, Garraux G.

Rev Med Liege · 2009-04-01

PMID: 19514544

Future directions: use of interventional MRI for cell-based therapy of Parkinson disease.

Roskom J, Swistowski A, Zeng X, Lim DA.

Neurosurg Clin N Am · 2009-04-01

DOI: 10.1016/j.nec.2009.04.005PMID: 19555884

[Study on the mechanism of electroacupuncture scalp point penetration therapy in action on apoptosis in the Parkinson's disease rat model].

Wang S, Jiang H, Qu L.

Zhongguo Zhen Jiu · 2009-04-01

PMID: 19565741

Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.

Sadan O, Shemesh N, Cohen Y, Melamed E, Offen D.

Isr Med Assoc J · 2009-04-01

PMID: 19603590

Evolution of Deep Brain Stimulation: Human Electrometer and Smart Devices Supporting the Next Generation of Therapy.

Lee KH, Blaha CD, Garris PA, Mohseni P, Horne AE, Bennet KE, Agnesi F, Bledsoe JM, Lester DB, Kimble C, Min HK, Kim YB, Cho ZH.

Neuromodulation · 2009-04-01

DOI: 10.1111/j.1525-1403.2009.00199.xPMID: 20657744

Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy.

Lee PH, Park HJ.

J Clin Neurol · 2009-03-31

DOI: 10.3988/jcn.2009.5.1.1PMID: 19513327

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.

Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF.

J Neurochem · 2009-03-28

DOI: 10.1111/j.1471-4159.2009.06074.xPMID: 19476553

COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE CONDITIONS AND METHODS FOR THE USE THEREOF

PIERSCHBACHER MICHAEL D.

· 2009-03-25

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING A SIDE EFFECT OF LEVODOPA WHICH IS A THERAPEUTIC AGENT FOR PARKINSON'S DISEASE

KOH JUNG-MIN.

· 2009-03-24

SCREENING METHODS USING CDNA MICROARRAY CHIP FOR THE DIAGNOSIS AND THE THERAPEUTIC CANDIDATES IN PARKINSON'S DISEASE

HONG MEE SOOK, PARK HI JOON, CHUNG JOO HO, LEE HYE JUNG.

· 2009-03-19